Education
About Us
Working with TipRanks
Follow Us
Bio-Works Technologies AB (DE:1BD)
FRANKFURT:1BD
1BD Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.04 - €0.20
Previous CloseN/A
Volume0.00
Average Volume (3M)688.00
Market Cap
€13.23M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Aug 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding78,733,460
10 Day Avg. Volume0
30 Day Avg. Volume688
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
1BD FAQ
What was Bio-Works Technologies AB’s price range in the past 12 months?
Bio-Works Technologies AB lowest stock price was €0.04 and its highest was €0.20 in the past 12 months.
What is Bio-Works Technologies AB’s market cap?
Bio-Works Technologies AB’s market cap is €13.23M.
When is Bio-Works Technologies AB’s upcoming earnings report date?
Bio-Works Technologies AB’s upcoming earnings report date is Aug 22, 2025 which is in 34 days.
How were Bio-Works Technologies AB’s earnings last quarter?
Bio-Works Technologies AB released its earnings results on May 15, 2025. The company reported -€0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.009.
Is Bio-Works Technologies AB overvalued?
According to Wall Street analysts Bio-Works Technologies AB’s price is currently Overvalued.
Does Bio-Works Technologies AB pay dividends?
Bio-Works Technologies AB does not currently pay dividends.
What is Bio-Works Technologies AB’s EPS estimate?
Bio-Works Technologies AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio-Works Technologies AB have?
Bio-Works Technologies AB has 78,733,460 shares outstanding.
What happened to Bio-Works Technologies AB’s price movement after its last earnings report?
Bio-Works Technologies AB reported an EPS of -€0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 22.222%.
Which hedge fund is a major shareholder of Bio-Works Technologies AB?
Currently, no hedge funds are holding shares in DE:1BD
Company Description
Bio-Works Technologies AB
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
Technical Analysis
Biosergen AB
―
Nanologica AB
―
Biovica International AB Class B
―
ExpreS2ion Biotech Holding AB
―
Active Biotech AB
―